These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 8029925)

  • 1. Lack of cross-species sensitization between skin allo- and xenotransplants in mice.
    Vizler C; Jánossy T; Tabi Z; Végh P
    Transplant Proc; 1994 Jun; 26(3):1324-5. PubMed ID: 8029925
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term survival and use of human skin xenografts in immunosuppressed mice.
    Jánossy T; Vizler C; Krizsa J; Hunyadi J; Kiss M; Nyirati I; Dobozy A; Végh P
    Transplant Proc; 1994 Jun; 26(3):1268-70. PubMed ID: 8029904
    [No Abstract]   [Full Text] [Related]  

  • 3. Extended skin allo- and xenograft survival in mice treated with rapamycin, antilymphocyte serum, and donor-specific bone marrow transfusion.
    Hale DA; Gottschalk R; Fukuzaki T; Wood ML; Maki T; Monaco AP
    Transplant Proc; 1996 Dec; 28(6):3269. PubMed ID: 8962269
    [No Abstract]   [Full Text] [Related]  

  • 4. Organ-specific tolerance induced by intrathymic injection of donor bone marrow cells and FK 506 or antilymphocyte serum in rat heart transplantation.
    Matsuura T; Imanishi M; Hara Y; Tahara H; Kanda H; Kurita T
    Transplant Proc; 1994 Aug; 26(4):1962-3. PubMed ID: 7520616
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of primary xenograft or allograft on the rejection of a subsequent allograft.
    Tchervenkov CI; Shum-Tim D; Serrick CJ; Gyopar A; Lough JO; Tchervenkov JI
    Transplant Proc; 1993 Feb; 25(1 Pt 1):453-4. PubMed ID: 8438376
    [No Abstract]   [Full Text] [Related]  

  • 6. Induction of immune unresponsiveness by intrathymic injection of allogeneic cells in a murine model.
    Sherburne CG; Onyekaba CO; Condie RM
    Transplant Proc; 1993 Feb; 25(1 Pt 1):307-11. PubMed ID: 8438313
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of adhesion molecules in islet allo- and xenograft rejection.
    Gotoh M; Ohzato H; Fukuzaki T; Ohta Y; Nishihara M; Hasuike Y; Umeshita K; Sakon M; Yagita H; Okumura K; Miyasaka M; Monden M
    Transplant Proc; 1996 Apr; 28(2):617. PubMed ID: 8623304
    [No Abstract]   [Full Text] [Related]  

  • 8. Induction of extended survival of rat skin xenografts in mice by pretreatment with intrathymic xenoantigen and antilymphocyte serum.
    Goss JA; Nakafusa Y; Uchiyama K; Flye MW
    Transplantation; 1992 Dec; 54(6):1101-3. PubMed ID: 1465777
    [No Abstract]   [Full Text] [Related]  

  • 9. Prolongation of skin xenograft survival with concomitant donor bone marrow transplantation.
    Jeyarajah DR; Schmeisser FS; Kadakia RA; Thistlethwaite JR
    Transplant Proc; 1994 Jun; 26(3):1201-2. PubMed ID: 8029886
    [No Abstract]   [Full Text] [Related]  

  • 10. Control of mouse-to-rat skin xenograft rejection by malononitrilamides.
    Schorlemmer HU; Kurrle R
    Transplant Proc; 1996 Dec; 28(6):3037-9. PubMed ID: 8962179
    [No Abstract]   [Full Text] [Related]  

  • 11. Rejection of human xenoskins by non-CD4 T-cell populations in mice.
    Uchida T; Tomita Y; Zheng QW; Kishihara K; Nomoto K; Yasui H
    Transplant Proc; 1996 Apr; 28(2):662. PubMed ID: 8623332
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of rapamycin on islet and skin xenograft survival.
    Bobbio SA; Porter JG; Monaco AP
    Transplant Proc; 1993 Aug; 25(4):2745-6. PubMed ID: 8356733
    [No Abstract]   [Full Text] [Related]  

  • 13. Survival of MHC deficient mouse heterotopic cardiac allografts and xenografts.
    Campos L; Deli BC; Kern JH; Kim JI; Naji A; Barker CF; Markmann JF
    Transplant Proc; 1995 Feb; 27(1):254-5. PubMed ID: 7878991
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of humoral immunity in pancreatic islet allo- and xenograft rejection.
    Ahn M; Sohn C; Chang E; Chu G; DeMatteo RP; Barker CF; Markmann JF
    Transplant Proc; 1996 Apr; 28(2):840-1. PubMed ID: 8623428
    [No Abstract]   [Full Text] [Related]  

  • 15. Synergistic effect of immunosuppressive drug and intrathymic inoculation of donor cells in skin graft survival.
    Dono K; Wood ML; Ozato H; Monaco AP
    Transplant Proc; 1994 Oct; 26(5):3061. PubMed ID: 7940963
    [No Abstract]   [Full Text] [Related]  

  • 16. Normal rejection of xenografts by strongly deficient B-cell animals (X-linked immunodeficient mice).
    Patselas T; Marchman W; Araneda D; Thomas J; Thomas F
    Transplant Proc; 1992 Apr; 24(2):494. PubMed ID: 1566401
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of HLA class II antigens/genes in xenogeneic iso, allo, and xeno transplantation.
    Tsuji K; Hagihara M; Sato T; Shimura T; Takebe K; Munkhbat B
    Transplant Proc; 1994 Aug; 26(4):2441-3. PubMed ID: 8066801
    [No Abstract]   [Full Text] [Related]  

  • 18. Augmentation by donor bone marrow of the survival of neonatal skin transplants to ALS-treated recipients.
    Gozzo JJ; Kowolenko M
    Transplant Proc; 1987 Feb; 19(1 Pt 1):470-1. PubMed ID: 3274809
    [No Abstract]   [Full Text] [Related]  

  • 19. Early up-regulation of CXC-chemokine expression is associated with strong cellular immune responses to murine skin xenografts.
    Lee EM; Park JO; Kim D; Kim JY; Oh KH; Park CG; Oh BH; Kim S; Ahn C
    Xenotransplantation; 2006 Jul; 13(4):328-36. PubMed ID: 16768726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac and skin xenograft survival in different recipient mouse strains.
    Gock H; Murray-Segal L; Salvaris E; Fisicaro N; Cowan PJ; d'Apice AJ
    Transplantation; 2006 Nov; 82(10):1362-9. PubMed ID: 17130786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.